Condensed Consolidated Statements of Stockholders’ Equity - USD ($) $ in Thousands	Total	Common Stock	Treasury Stock	Additional Paid-in Capital	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2024		109,159,697
Beginning balance at Dec. 31, 2024	$ 174,307	$ 11	$ 0	$ 659,488	$ (485,192)
Beginning balance (in shares) at Dec. 31, 2024			0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	3,254				3,254
Stock options exercised (in shares)		75,000
Stock options exercised	384			384
Stock-based compensation	2,412			2,412
Vested restricted stock units (in shares)		1,253,999
Ending balance (in shares) at Mar. 31, 2025		110,488,696
Ending balance at Mar. 31, 2025	180,357	$ 11	$ 0	662,284	(481,938)
Ending balance (in shares) at Mar. 31, 2025			0
Beginning balance (in shares) at Dec. 31, 2024		109,159,697
Beginning balance at Dec. 31, 2024	174,307	$ 11	$ 0	659,488	(485,192)
Beginning balance (in shares) at Dec. 31, 2024			0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	7,883
Ending balance (in shares) at Sep. 30, 2025		112,123,757
Ending balance at Sep. 30, 2025	190,185	$ 11	$ 0	667,484	(477,310)
Ending balance (in shares) at Sep. 30, 2025			0
Beginning balance (in shares) at Mar. 31, 2025		110,488,696
Beginning balance at Mar. 31, 2025	180,357	$ 11	$ 0	662,284	(481,938)
Beginning balance (in shares) at Mar. 31, 2025			0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	3,870				3,870
Stock-based compensation	2,716			2,716
Vested restricted stock units (in shares)		1,093,352
Shares issued under employee stock purchase plan (in shares)		18,189
Shares issued under employee stock purchase plan	85			85
Ending balance (in shares) at Jun. 30, 2025		111,600,237
Ending balance at Jun. 30, 2025	187,028	$ 11	$ 0	665,085	(478,068)
Ending balance (in shares) at Jun. 30, 2025			0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	758				758
Stock-based compensation	2,399			2,399
Vested restricted stock units (in shares)		523,520
Ending balance (in shares) at Sep. 30, 2025		112,123,757
Ending balance at Sep. 30, 2025	$ 190,185	$ 11	$ 0	667,484	(477,310)
Ending balance (in shares) at Sep. 30, 2025			0
Beginning balance (in shares) at Dec. 31, 2025	112,809,637	112,809,637
Beginning balance at Dec. 31, 2025	$ 169,669	$ 11	$ 0	670,536	(500,878)
Beginning balance (in shares) at Dec. 31, 2025	0		0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	$ (42)				(42)
Repurchase of common stock, net of excise taxes and fees (in shares)			1,052,672
Repurchase of common stock, net of excise taxes and fees	(3,000)		$ (3,000)
Stock-based compensation	2,465			2,465
Vested restricted stock units (in shares)		917,646
Ending balance (in shares) at Mar. 31, 2026		113,727,283
Ending balance at Mar. 31, 2026	$ 169,092	$ 11	$ (3,000)	673,001	(500,920)
Ending balance (in shares) at Mar. 31, 2026			1,052,672
Beginning balance (in shares) at Dec. 31, 2025	112,809,637	112,809,637
Beginning balance at Dec. 31, 2025	$ 169,669	$ 11	$ 0	670,536	(500,878)
Beginning balance (in shares) at Dec. 31, 2025	0		0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	$ 101,964
Repurchase of common stock, net of excise taxes and fees (in shares)	7,200,000
Repurchase of common stock, net of excise taxes and fees	$ (25,000)
Stock options exercised (in shares)	1,527,406
Ending balance (in shares) at Sep. 30, 2026	116,694,683	116,694,683
Ending balance at Sep. 30, 2026	$ 263,016	$ 12	$ (25,240)	687,158	(398,914)
Ending balance (in shares) at Sep. 30, 2026	7,214,231		7,214,231
Beginning balance (in shares) at Mar. 31, 2026		113,727,283
Beginning balance at Mar. 31, 2026	$ 169,092	$ 11	$ (3,000)	673,001	(500,920)
Beginning balance (in shares) at Mar. 31, 2026			1,052,672
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	10,687				10,687
Repurchase of common stock, net of excise taxes and fees (in shares)			4,522,911
Repurchase of common stock, net of excise taxes and fees	(15,882)		$ (15,882)
Stock-based compensation	3,015			3,015
Vested restricted stock units (in shares)		888,315
Shares issued under employee stock purchase plan (in shares)		47,524
Shares issued under employee stock purchase plan	108			108
Ending balance (in shares) at Jun. 30, 2026		114,663,122
Ending balance at Jun. 30, 2026	167,020	$ 11	$ (18,882)	676,124	(490,233)
Ending balance (in shares) at Jun. 30, 2026			5,575,583
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	91,319				91,319
Repurchase of common stock, net of excise taxes and fees (in shares)			1,638,648
Repurchase of common stock, net of excise taxes and fees	(6,358)		$ (6,358)
Stock options exercised (in shares)		1,527,406
Stock options exercised	7,893	$ 1		7,892
Stock-based compensation	$ 3,142			3,142
Vested restricted stock units (in shares)		504,155
Ending balance (in shares) at Sep. 30, 2026	116,694,683	116,694,683
Ending balance at Sep. 30, 2026	$ 263,016	$ 12	$ (25,240)	$ 687,158	$ (398,914)
Ending balance (in shares) at Sep. 30, 2026	7,214,231		7,214,231